Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOaktree Acquisition Corp. III Life Sciences Unit Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2025 | Q3 2025 | N/A | $0.08 | N/A | N/A | $0 |
| 08/12/2025 | Q2 2025 | N/A | $0.08 | N/A | N/A | $0 |
| 05/14/2025 | Q1 2025 | N/A | $0.07 | N/A | N/A | $0 |
| 03/27/2025 | Q4 2024 | N/A | $0.06 | N/A | N/A | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$0.00 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Oaktree Acquisition Corp. III Life Sciences Unit Earnings: FAQ's
Oaktree Acquisition Corp. III Life Sciences Unit has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, September 16th, 2025 based offlast year's report dates.
The conference call for Oaktree Acquisition Corp. III Life Sciences Unit's latest earnings report can be listened to online.
The conference call transcript for Oaktree Acquisition Corp. III Life Sciences Unit's latest earnings report can be read online.
Oaktree Acquisition Corp. III Life Sciences Unit (:OACCU) has a recorded net income of $2.66 K.Oaktree Acquisition Corp. III Life Sciences Unit has generated $0.0542 earnings per share over the last four quarters.
Oaktree Acquisition Corp. III Life Sciences Unit (:OACCU) has a price-to-earnings ratio of 29.51 and price/earnings-to-growth ratio is 0.74.